Literature DB >> 17612502

An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder.

Carolyn Black Becker1, Ellen Darius, Katherine Schaumberg.   

Abstract

Although several efficacious treatments for posttraumatic stress disorder (PTSD) exist, these treatments are currently underutilized in clinical practice. To address this issue, research must better identify barriers to dissemination of these treatments. This study investigated patient preferences for PTSD treatment given a wide range of treatment options in an analog sample. One hundred and sixty individuals, with varying degrees of trauma history, were asked to imagine themselves undergoing a trauma, developing PTSD, and seeking treatment. Participants evaluated seven different treatment descriptions, which depicted treatment options that they might encounter in a clinical setting. Participants rated their most and least preferred treatments along with their personal reactions to and the perceived credibility of each treatment. Participants also completed a critical thinking skills questionnaire. Participants predominantly chose exposure or another variant of cognitive-behavioral therapy as their most preferred therapy, and those who chose exclusively empirically supported treatments evidenced higher critical thinking skills. The present study contributes to a growing literature indicating that patients may be more interested in these therapies than indicated by utilization rates. The problem of underutilization of empirically supported treatments for PTSD in clinical practice may be due to therapist factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612502     DOI: 10.1016/j.brat.2007.05.006

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  24 in total

1.  Effects of Intervention Characteristics on Willingness to Initiate a Weight Gain Prevention Program.

Authors:  Megan A McVay; Marissa L Donahue; JeeWon Cheong; Joseph Bacon; Michael G Perri; Kathryn M Ross
Journal:  Am J Health Promot       Date:  2020-02-20

2.  Patient preferences for obsessive-compulsive disorder treatment.

Authors:  Sapana R Patel; Helen Blair Simpson
Journal:  J Clin Psychiatry       Date:  2010-11       Impact factor: 4.384

Review 3.  Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.

Authors:  Therese K Killeen; Sudie E Back; Kathleen T Brady
Journal:  Drug Alcohol Rev       Date:  2015-03-04

4.  Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD.

Authors:  Melanie S Harned; Mathew A Tkachuck; Kelly A Youngberg
Journal:  J Clin Psychol       Date:  2013-02-26

5.  Providing a treatment rationale for PTSD: does what we say matter?

Authors:  Norah C Feeny; Lori A Zoellner; Shoshana Y Kahana
Journal:  Behav Res Ther       Date:  2009-06-21

6.  What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.

Authors:  Lori A Zoellner; Norah C Feeny; Joyce N Bittinger
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-06-12

7.  Treatment challenges associated with comorbid substance use and posttraumatic stress disorder: clinicians' perspectives.

Authors:  Sudie E Back; Angela E Waldrop; Kathleen T Brady
Journal:  Am J Addict       Date:  2009 Jan-Feb

8.  Exposure-based cognitive-behavioral treatment of PTSD in adults with schizophrenia or schizoaffective disorder: a pilot study.

Authors:  B Christopher Frueh; Anouk L Grubaugh; Karen J Cusack; Matthew O Kimble; Jon D Elhai; Rebecca G Knapp
Journal:  J Anxiety Disord       Date:  2009-02-14

9.  "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.

Authors:  Jessica A Chen; Stephanie M Keller; Lori A Zoellner; Norah C Feeny
Journal:  J Nerv Ment Dis       Date:  2013-08       Impact factor: 2.254

10.  Assessment of preferences for treatment: validation of a measure.

Authors:  Souraya Sidani; Dana R Epstein; Richard R Bootzin; Patricia Moritz; Joyal Miranda
Journal:  Res Nurs Health       Date:  2009-08       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.